Thomas R Fleming

9PUBLICATIONS
16CO-AUTHORS
Epidemiological methodsMolecular targetsMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 21, 2025
A Perspective on the Appropriate Implementation of ICH E9(R1) Addendum Strategies for Handling Intercurrent Events.

Thomas R Fleming, Kevin J Carroll, Janet T Wittes

|Feb 13, 2024
Methods for the estimation of direct and indirect vaccination effects by combining data from individual- and cluster-randomized trials.

Rui Wang, Mengqi Cen, Yunda Huang

|Apr 25, 2023
Finding the (biomarker-defined) subgroup of patients who benefit from a novel therapy: No time for a game of hide and seek.

Lisa Meier McShane, Mark D Rothmann, Thomas R Fleming

|Jul 22, 2022
A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threats.

Ira M Longini, Yang Yang, Thomas R Fleming

|May 27, 2021
COVID-19 vaccine trials: The potential for "hybrid" analyses.

Thomas R Fleming, Martha Nason, Philip R Krause

|Feb 04, 2021
COVID-19 vaccine trials: The use of active controls and non-inferiority studies.

Thomas R Fleming, Philip R Krause, Martha Nason

Pageof 2

Frequent Collaborators

3 joint publications

Ira M Longini

2 joint publications

Susan S Ellenberg

1 joint publications

Davey Smith

1 joint publications

Laura Smeaton